Corbus Culture:

Our passion. Our purpose. At Corbus, it starts at our core. 

We look for unique talent. Our people are brilliant, they break barriers and are not defined by a title. Eclectic experiences make Corbus a special place to share ideas and grow. At Corbus, transformative ideas can come from anyone, anywhere and anytime. We offer our team flexibility and the opportunity to excel in their professional journey. We provide a welcoming space where collaboration, mentorship and diversity are encouraged. We come together, like no other, to elevate each other and focus on what’s best for patients. 

About Corbus

Corbus is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Our pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, a next-generation antibody drug conjugate (“ADC”) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (“CB1”) receptor inverse agonist for the treatment of obesity. Corbus is headquartered in Norwood, Massachusetts. For more information on Corbus, visit corbuspharma.com. Connect with us on Twitter, LinkedIn and Facebook.

Corbus Pharmaceuticals Holdings, Inc. is an equal opportunity employer

General Description:

As a pivotal member of the Corbus Product Development Team(s) (PDT) supports Corbus’ drug development by developing and overseeing the execution of regulatory strategy in the US/EU and other territories deemed applicable. 

Responsibilities:

• Collaborate with the leadership team to develop Regulatory Strategy as part of an integrated development plan for each Corbus asset including inclusion/adoption of accelerated regulatory pathways where possible.
• Proactively identifying regulatory risks and working with the Corbus Product Development Team to mitigate those risks.
• Leading working groups tasked with developing regulatory submissions e.g. IND working group.
• Overseeing clinical trials submissions performed by Contract Research Organizations (CRO) ensure timely and good quality submissions supportive of the overall
• Providing regulatory input on safety documentation e.g. Development Safety Update Report (DSUR), Investigator’s Brochure (IBs)
• Providing regulatory input on clinical documentation as required e.g. Protocols, Clinical Study Reports (CSR)
• Reviewing external communications e.g. Publications, Press Releases, Clinicaltrial.gov postings for regulatory compliance
• Identifying and managing subject matter experts engaged to support regulatory activities
• Ensuring that Corbus has a complete record of all regulatory submissions made by the company or on behalf of the company.

Qualifications and Experience:

• Bachelor’s Degree in life sciences
• Higher degree preferred or equivalent experience
• 15+ years’ experience in biotech or pharma with 10+ years in Regulatory Affairs
• Experience in all types of regulatory submissions including but not limited to INDs, NDAs, MAA, Type A-D Meetings with FDA, Scientific Advice Consultations with the CHMP of EMA and MHRA, MAA.
• Experience with filing Orphan Drug Designations (ODD), FastTrack, Breakthrough Designations (BTD) and Priority Medicines Initiatives (PRIME) and other accelerated regulatory pathways ideal.
• Ideally this role will be located in Norwood, Massachusetts as a hybrid role 3 days onsite weekly but flexible for remote candidates open to travel monthly to Norwood, Massachusetts.

Qualities:

• Demonstrate a collaborative leadership style within the Product Development Team when providing regulatory expertise.
• Prepared to be hands-on as well thinking strategically.
• Communicate well with internal and external stakeholders.
• Be able to effectively articulate to Senior Management regulatory risk and the potential impact.